| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |